License U of T Technologies

Who is this for?

Industry and other parties interested in licensing or otherwise using University of Toronto (U of T) technologies or working with spinoff companies based on U of T intellectual property.

What do I need before I can begin?

No information is required to begin. If you have questions regarding licensing University of Toronto (U of T) technologies or working with our spinoff companies, please reach out to the Innovations & Partnerships Office: Director, Innovations at 416-946-5515.

Technology Licensing & Startup Opportunities

The University of Toronto (U of T) is a global leader in turning research into products, services, companies and jobs. The Innovations & Partnerships Office (IPO) is your one-stop-shop to license these technologies or work with spinoff companies based on U of T intellectual property (IP). IPO’s team of technology transfer professionals makes the process as quick and easy as possible.

Use our technology explorer to discover market-ready innovations and companies based on U of T IP or contact us to find custom solutions.
 

Technology Keywords
Recombinant Antibodies Network (RAN) Antibodies , Cancer , Advanced Health Technologies , Biotechnology , Pharmaceuticals , Therapeutics 
Targeting the Hippo Pathway for Cancer & Fibrosis Advanced Health Technologies , Biotechnology , Cancer , Cell Signaling , Drug Discovery , Health & Related Life Sciences , Inflammation , Pharmaceuticals , Small Molecules , Therapeutics 
Inhibition of PKN1 As Therapy For Chronic Lymphocytic Leukemia (CLL) Advanced Health Technologies , Biotechnology , Cancer , Drug Discovery , Health & Related Life Sciences , Leukemia , Pharmaceuticals , Small Molecules , Therapeutics 
Excimer-Based Molecular Tool for Detection of Proximally Phosphorylated Protein Sites Cancer , Detection Methods , Fluorescent sensors , Proteins , Sensors & Instrumentation 
Mammalian Membrane Two-Hybrid (MaMTH) Technology: a Novel Protein Interaction and Drug Discovery Tool Cancer , Cell Signaling , Disease Detection , Drug Discovery , Genetics , Membrane Proteins , Neurological Disorders , Protein-Protein Interactions , Proteins 
Measurement of Rodent Interaction with a Cage Lid Cancer , Neurological Disorders , Sensors & Instrumentation , Sensory Systems & Rehabilitation 
MNAzyme-Based Gold Nanoparticle Sensor Cancer , Diagnostics , Disease Detection , Medical Devices , Nanomaterials and Nanoparticles , Patient Care , Point-of-Care , Sensors & Instrumentation 
Multiplexed Genetic Detection with Isothermal Signal Amplification Cancer , Chips , Diagnostics , Disease Detection , Genetics , Infectious Diseases , Nanomaterials and Nanoparticles , Point-of-Care , Polymers , Quantum Dots , Smartphones 
Nanoparticle-based Thermal Contrast Agents Cancer , Diagnostics , Disease Detection , Infectious Diseases , Nanomaterials and Nanoparticles 
ReFilx: Regenerative Filler Matrix for permanent restoration of breast tissue following lumpectomy Biomaterials , Cancer , Companies , Nanomaterials and Nanoparticles , Polymers , Tissue Engineering 

VPRI Role

  • Market U of T technologies to industry
  • Support the development of startup companies
  • Negotiate license agreements with interested companies
  • Assist in finding partners and funding to support proof-of-concept and commercialization
  • Support long-term relationships with strategic partners that help develop early-stage discoveries into market-ready technologies and products

VPRI Contact

Staff

Jennifer Fraser

Director, Innovations
Innovations & Partnerships Office (IPO)
(416) 946-5515
Radio Options- Did you find this useful?
Did you find this useful?
Let us know if you found this page useful. Did you find the information you were looking for?